Race Oncology Limited (RAONF)
USD 1.22
(0.0%)
USD 1.22
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -14.2 Million AUD | -11.17% |
| 2023 | -12.77 Million AUD | -9.45% |
| 2022 | -7.73 Million AUD | -66.24% |
| 2021 | -4.65 Million AUD | -83.6% |
| 2020 | -2.53 Million AUD | -3.67% |
| 2019 | -2.44 Million AUD | 45.59% |
| 2018 | -4.49 Million AUD | -54.39% |
| 2017 | -2.9 Million AUD | -687.28% |
| 2016 | -369.47 Thousand AUD | -14003.04% |
| 2015 | 2657.48 AUD | -0.81% |
| 2014 | 2679.30 AUD | -1.59% |
| 2013 | 2722.57 AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -5.38 Million USD | 0.0% |
| 2024 Q2 | -6.44 Million USD | 0.0% |
| 2023 Q4 | -4.84 Million USD | 0.0% |
| 2023 FY | - AUD | -9.45% |
| 2023 Q2 | -3.69 Million USD | 0.0% |
| 2022 Q2 | -3.72 Million USD | 0.0% |
| 2022 FY | - AUD | -66.24% |
| 2022 Q4 | -4.18 Million USD | 0.0% |
| 2021 Q4 | -2.97 Million USD | 0.0% |
| 2021 FY | - AUD | -83.6% |
| 2021 Q2 | -1.72 Million USD | 0.0% |
| 2020 Q4 | -1.53 Million USD | 0.0% |
| 2020 Q2 | -1.01 Million USD | 0.0% |
| 2020 FY | - AUD | -3.67% |
| 2019 FY | - AUD | 45.59% |
| 2019 Q4 | -1.01 Million USD | 0.0% |
| 2018 FY | - AUD | -54.39% |
| 2017 FY | - AUD | -687.28% |
| 2016 FY | - AUD | -14003.04% |
| 2015 FY | - AUD | -0.81% |
| 2014 FY | - AUD | -1.59% |
| 2013 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 80.005% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -139.561% |
| SQZ Biotechnologies Company | -64.14 Million USD | 77.856% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 18.23% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 115.104% |
| Mesoblast Limited | -62.38 Million USD | 77.234% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -824.669% |
| Genus plc | 73.7 Million USD | 119.272% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -114.828% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -300.434% |
| Marizyme, Inc. | -34.28 Million USD | 58.568% |
| ContraFect Corporation | -64.99 Million USD | 78.148% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -61.917% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -213.804% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -913.218% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -437.102% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -511.208% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -2641.721% |
| Accustem Sciences Inc. | -3.74 Million USD | -279.119% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 70.549% |
| EV Biologics, Inc. | -1.26 Million USD | -1020.907% |
| Q BioMed Inc. | -617.62 Thousand USD | -2199.665% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 497.631% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -2145.927% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -521.731% |
| Biomind Labs Inc. | -1.03 Million USD | -1272.905% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 243.803% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -98.336% |
| Skye Bioscience, Inc. | -13.54 Million USD | -4.841% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -854.905% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -56713.504% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -265.659% |
| IMV Inc. | -35.52 Million USD | 60.017% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 10.5% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -467.69% |
| GB Sciences, Inc. | -1.41 Million USD | -900.319% |
| Alpha Cognition Inc. | -9.7 Million USD | -46.342% |
| HST Global, Inc. | -5303.00 USD | -267736.621% |
| CSL Limited | 4.78 Billion USD | 100.297% |
| Halberd Corporation | -74.27 Thousand USD | -19021.658% |
| Enzolytics Inc. | -2.12 Million USD | -569.33% |
| Resverlogix Corp. | -11.74 Million USD | -20.962% |
| Affymax, Inc. | -14.29 Million USD | 0.641% |
| SYBLEU INC | -141.57 Thousand USD | -9932.687% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -363.706% |
| argenx SE | -216.02 Million USD | 93.425% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 74.334% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 1267.081% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -847.583% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 3849.136% |
| AVAX Technologies, Inc. | -6.11 Million USD | -132.361% |
| Zenith Capital Corp. | -8.6 Million USD | -65.04% |
| Genscript Biotech Corporation | -248.71 Million USD | 94.289% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -81430.199% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -480.568% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -7968.983% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 64.166% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -391.071% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -1257.47% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 211334.027% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -711.622% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -639.408% |
| BioStem Technologies, Inc. | -7.55 Million USD | -88.033% |
| ONE Bio Corp. | 13.61 Million USD | 204.337% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -7743.356% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -590.49% |
| Agentix Corp. | -1.37 Million USD | -935.416% |
| LadRx Corporation | 412.28 Thousand USD | 3545.055% |
| Cell Source, Inc. | -4.27 Million USD | -232.435% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -3767.801% |
| Regen BioPharma, Inc. | 1.46 Million USD | 1068.881% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -1415.918% |
| NovAccess Global Inc. | -1.03 Million USD | -1272.576% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 260.421% |
| Itoco Inc. | -1.86 Million USD | -659.947% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -3641.472% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -1172.704% |
| Kadimastem Ltd | -2.62 Million USD | -441.209% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -5839.108% |
| CytoDyn Inc. | -18.02 Million USD | 21.219% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -17872.36% |
| Mobile Lads Corp. | -2.24 Million USD | -533.751% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -116045.032% |
| Qrons Inc. | -40.08 Thousand USD | -35336.681% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -2824.443% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 2792.925% |
| Rebus Holdings, Inc. | -951 Thousand USD | -1393.52% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -1237.405% |
| International Stem Cell Corporation | 202 Thousand USD | 7131.374% |
| Bioxytran, Inc. | -3.82 Million USD | -271.802% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -26882.097% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -476.92% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 60.402% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -31463.058% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -418.75% |
| Neutra Corp. | -181.24 Thousand USD | -7736.475% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 29.543% |
| PureTech Health plc | -11.62 Million USD | -22.159% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 29.538% |
| IXICO plc | -707 Thousand USD | -1908.964% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -84.819% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 70.621% |
| CSL Limited | 4.73 Billion USD | 100.3% |
| Cellectis S.A. | -92.63 Million USD | 84.668% |